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Intrauterine growth restriction (IUGR) leads to small for gestational age (SGA) neonates, 
increasing risk of brain and cognitive impairments that persist into adulthood. Human milk 
oligosaccharides (HMO) have been postulated to exert positive effects on brain development. 
HMOs are the third most abundant solid component of breast milk with 2ʹ-fucosyllactose (2ʹFL) 
being the most abundant HMO. We aimed to determine whether orally administered 2ʹFL 
enhances brain and cognitive development in small for gestational aged neonates. Sex-matched, 
littermate pairs of SGA (0.5-0.9kg) and appropriate for gestational age (AGA, 1.3-1.8kg) piglets 
were acquired on postnatal day (PD) 2, placed in individual cages, and divided into two diet 
groups. One group was provided a sow milk replacer diet (300ml/kg/d) while the other received 
the same diet supplemented with 2ʹFL (1.17g/L). On PD 14, spatial learning was assessed using 
a T-maze task, and on PD 28, brain macrostructure, microstructure, and hippocampal metabolites 
were assessed by magnetic resonance imaging. A sub-set of pigs was euthanized at PD14 and 
hippocampal tissue was dissected and used for RNA-sequencing. Body weight was different 
between SGA and AGA throughout the course of the study (p<0.05), with 2ʹFL having no effect. 
At PD 28, the brain-to-body-weight ratio of SGA piglets was greater than that of AGA piglets 
(p<0.0001), suggesting a “brain-sparing” effect during IUGR. The brain-to-body-weight ratio 
was not affected by 2ʹFL. Performance of all piglets during acquisition and reversal phases of the 
spatial T-maze task improved over time (p<0.0001), but SGA piglets reached criterion faster 
than AGA piglets (p<0.05), with no effect of diet. MRI revealed 12 brain regions (p<0.01) that 
were larger in AGA than SGA piglets. Furthermore, SGA piglets had less grey matter than AGA 
(p<0.001) in 4 subcortical regions and reduced whole brain fractional anisotropy (p<0.01) 
suggesting lower white matter integrity. No effects of 2ʹFL on brain structure were found. RNA-
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sequencing revealed 529 differentially expressed genes (DEGs) in hippocampal tissue (p<0.006). 
A total of 115 DEGs were identified in response to size, of which 62 were up-regulated and 53 
were down-regulated in SGA piglets compared to AGA piglets. Up-regulated genes in SGA 
piglets were associated with chromatin silencing, DNA binding, nuclear chromatin, and the 
nucleosome; and down-regulated genes in SGA piglets were associated with KEGG pathways 
for measles, influenza A, hepatitis C, and herpes simplex infection. A main effect of diet 
revealed 252 DEGs, of which 144 up-regulated and 108 down-regulated genes in 2ʹFL piglets 
compared to CON. Genes that were up-regulated in response to 2ʹFL were connected to integral 
components of membranes and transmembrane helix, while down-regulated genes were clustered 
based on ion channel and transport, zinc ion binding, zinc-finger, and metal-binding. Finally, in 
the size by diet interaction, there were no clusters discovered as a result of up-regulated gene 
expression, however, down-regulated genes were associated with transmembrane helix, 
membranes, and integral components of membrane. Collectively, the results show that neonates 
born SGA have altered brain structure and hippocampal gene expression.  While 2ʹFL did not 
have measureable effects on brain structure or spatial learning in either SGA or AGA piglets, it 
elicited a distinct gene expression profile in the hippocampus suggesting epigenetic 
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Intrauterine growth restriction (IUGR) often leads to small for gestational age (SGA) 
neonates, increasing the risk of perinatal morbidity and mortality (1). IUGR can be defined as 
impaired growth and development of an embryo/fetus or its organs during pregnancy (2) and is 
observed in approximately 24% of newborn human infants annually (3). An infant is classified as 
SGA if it has a birth weight in the lower 10th percentile for its gestational age (4). While IUGR 
and SGA are associated with several health problems throughout life, studies have shown a 
connection with neurodevelopmental disabilities in cognitive function, recognition memory, 
attention, mood, and school performance (5, 6).  
Robust growth and expansion of the brain occurs during the last trimester and the first year of 
life (7, 8). During this period, the brain is vulnerable to insults that may be mitigated with proper 
early-life nutrition. One brain region particularly susceptible to these perinatal stressors is the 
hippocampus, a region involved in learning and memory (9). These deficits often persist into 
adulthood (10), and therefore, it is imperative to develop efficacious interventions for reversing 
or mitigating the cognitive impairments associated with being born SGA due to IUGR.  
Human milk is commonly referred to as the “gold standard” of infant nutrition. It contains all 
of the essential nutrients for the growth and development of the infant as well as provides 
infectious disease protection (11-13) and has been shown to improve cognitive development (14, 
15). In addition to the traditional nutrients, breast milk contains a variety of functional 
ingredients that may provide a health benefit to the infant (16). One of these functional 
ingredients are human milk oligosaccharides (HMOs). HMOs are the third most abundant solid 
component of breast milk and contain a range of structurally diverse unconjugated glycans (17). 
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There have been a variety of postulated beneficial effects for HMOs. Research suggests that 
HMOs act as antiadhesive antimicrobials that serve as soluble decoy receptors to prevent 
pathogen adhesion (17). Furthermore, they regulate epithelial and immune cell responses (18), 
regulate lymphocyte cytokine production (17), and modulate the intestinal microbiota (16, 17, 
19). While there are approximately 200 different complex oligosaccharides (16), this study 
focuses on 2ʹ-fucosyllactose (2ʹFL), the most abundant HMO. A growing body of evidence 
suggests 2ʹFL has anti-infective properties, acts as a prebiotic to feed beneficial bacteria (20), 
and enhances cognitive development (21-23).  
Understanding the influence of 2ʹFL and IUGR on brain and cognitive development has been 
slow due to obvious ethical considerations when studying human infants; therefore, the neonatal 
piglet appears to be an excellent model. In regards to neurodevelopment, the piglet has many 
similarities to the perinatal growth pattern and structure of the human brain (24, 25). 
Furthermore, the distribution of grey and white matter of the neonatal piglet brain is similar to 
that of human infants (26). In pigs, IUGR is naturally occurring and often caused by placental 
insufficiency and multifetal pregnancy (27). In humans, it is often difficult to tell gestational age, 
but because artificial insemination is used in our system and the time of conception is known, the 
effects of being born SGA can be differentiated from the effects of being born preterm and low 
birth weight (27). Thus, the SGA piglet is an excellent model for assessing the neurological 
effects of nutritional interventions in SGA infants during the neonatal period. This study aims to 
determine whether orally administered 2ʹFL enhances hippocampal-dependent learning and 










2.1 INTRAUTERINE GROWTH RESTRICTION (IUGR), SMALL FOR 
GESTATIONAL AGE (SGA) AND APPROPRIATE FOR GESTATIONAL AGE (AGA) 
 
2.1.1 Definition of IUGR, SGA, AGA  
Intrauterine growth restriction (IUGR) occurs when an infant fails to attain his or her in 
utero growth potential (28). This can have a lifelong influence on the neonates potential for 
development and survival. Small for gestational age (SGA) neonates often result from IUGR. An 
infant is classified as SGA if it has a birth weight in the lower 10th percentile for its gestational 
age (4). In humans, it is often difficult to determine the gestational age of a neonate because the 
time of conception is not always known. Using these definitions, all IUGR infants can be 
categorized as SGA, but not all SGA infants will be IUGR.  
The SGA infant may be symmetrically or asymmetrically small at birth compared to its 
appropriate for gestational age (AGA) counterpart. Symmetrically growth restricted infants have 
overall reduced weight, length, and head circumference at birth (28). Infants with asymmetric 
growth restriction typically have spared head growth relative to weight and length (28). Yet, both 
types of SGA infants have increased risk of perinatal morbidity and mortality, and this risk 
increases with the decrease in birth weight percentile (29). Due to the fact that many clinical 
studies regarding IUGR infants often include those that are SGA due to other reasons, these 
terms will be used interchangeably in this review.  
 
2.1.2 Causes of IUGR and SGA  
It is important for clinicians to determine the causes of the growth restriction in order to 
develop efficacious interventions in reducing the incidence or severity of the condition. The 
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causes of IUGR are diverse, and poor fetal growth often reflects a combination of maternal, fetal, 
and placental factors. Maternal conditions associated with IUGR include medical complications 
(e.g. hypertension, diabetes, severe chronic infection), ethnicity, pre-pregnancy weight and 
pregnancy weight gain, and low maternal age (4). Epidemiological research has also shown a 
connection between environmental factors such as smoking, alcohol, high altitude, and low 
socioeconomic status and incidence of IUGR (4). Among those factors, cigarette smoking 
appears to be the most influential cause of IUGR. Moreover, fetal conditions associated with 
IUGR include genetic factors (i.e. chromosomal abnormalities and mutations), infections, and 
malformations such as cardiovascular, gastrointestinal, and skeletal defects (4). IUGR can also 
be caused by placental insufficiency. This is a pathological condition that results in the poor 
transfer of nutrients and potentially oxygen to the fetus (30). IUGR is observed in approximately 
24% of newborn human infants annually (3); therefore, it is important to understand the 
pathophysiology of this condition. 
 
2.1.3 Effects of SGA and IUGR on gastrointestinal development  
Infants born SGA are subjected to feeding intolerance, lower fat absorption, and digestive 
diseases early in life (31). Research has shown changes in the intestines of IUGR neonates 
including reduced weight, length, wall thickness, villus height, and crypt depth (32). 
Furthermore, SGA infants show lower efficiency of nutrient utilization when compared to their 
AGA counterparts (33). Yet, due to ethical considerations, the pathophysiology of growth 
restriction on the gastrointestinal tract has been difficult to investigate in human infants. 
Therefore, animal models have been utilized to help advance the knowledge IUGR and its effect 
on gastrointestinal development.   
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A recent study explored the effects of IUGR on small intestinal mucosal permeability 
using a neonatal piglet model (33). FITC-dextran 4 and horseradish peroxidase fluxes, 
histomorphologic measurements, and gene expression of tight-junction proteins were used to 
assess epithelial barrier function. The results showed that intestinal permeability was 2-fold 
higher in the proximal intestine on postnatal day 0 in IUGR piglets. This suggests a 
compromised barrier function, which could be detrimental to the health of IUGR neonates. A 
disrupted barrier function could allow the translocation of antigens and/or bacteria leading to 
inflammatory responses. 
 Another study using a neonatal piglet model aimed to determine the effects of IUGR on 
intestinal structure and function (34). Control or IUGR newborn piglets were delivered by 
cesarean section at full term or premature (91% gestation). While organ weights and intestinal 
enzyme activities were not notably affected by IUGR for term or pre-term piglets, IUGR piglets 
were associated with a relatively long and thin intestine. Moreover, IUGR piglet ileum appeared 
to be developmentally delayed such that they had lower ileal density and villus area, higher 
expression of the peptide transporter PEPT1, and enhanced bacterial adhesion and translocation. 
The elevated expression of PEPT1 could potentially result in a decreased barrier function 
enhancing intestinal transport of bacterial peptides. Taken together, these studies further develop 
our understanding of the IUGR neonate’s increased risk of perinatal morbidity and mortality.  
 
2.1.4 Effects of SGA and IUGR on neurodevelopment  
Epidemiological research has shown that SGA and IUGR neonates have an increased risk 
of cognitive impairments that persist into adulthood. A 26-year follow up study of the 1970 
British Birth Cohort aimed to determine the long-term functional outcome of SGA infants (35). 
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School performance and achievement were assessed at ages 5, 10, and 16 years, and years of 
education, occupational status, income, marital status, life satisfaction, disability, and height 
were measured at 26 years in a total of 14,189 full-term infants (1,064 SGA). The results at 5, 
10, and 16 years showed that SGA neonates displayed small but significant deficits in academic 
achievement. For example, teachers were more likely to recommend special education and less 
likely to rank those born SGA in the top 15th percentile of the class at 16 years. Yet, at age 26, 
those born SGA did not present any differences in years of education, employment, marital 
status, or life satisfaction. However, they were less likely to hold managerial or professional jobs 
as well as have lower levels of weekly income. Collectively, these results show that adults born 
SGA had significant differences in academic and professional achievement compared to AGA 
adults. Nevertheless, there were no notable social or emotional consequences of being born SGA 
at age 26.  
Another study followed a total of 7,388 term infants from birth to 14 years to determine if 
the presence, severity, or symmetry of growth restriction is a risk factor for learning, cognitive, 
and attention problems in adolescence (36). The results showed that adolescents born SGA were 
more likely to experience learning difficulties, as measured using the Wide Range Achievement 
Test (WRAT) reading subtest. However, using the Ravens IQ test, there was no significant 
difference between SGA and AGA groups for either male or female children. Furthermore, there 
was no connection between body symmetry and any of the outcomes studied. Thus, it was 
concluded that SGA status at birth has slight effects on learning, cognition, and attention in 




2.2 NUTRITION FOR THE NEONATE  
2.2.1 Human milk (HM) vs. infant formula (IF) 
Human milk is commonly referred to as the “gold standard” of infant nutrition. The 
American Academy of Pediatrics (AAP) recommends that infants be exclusively breastfed for 
the first six months of life (37). Solid foods are to be gradually introduced into the infant’s diet in 
addition to breastfeeding until the infant is one year old. According to the latest National 
Immunization Survey data, in the US, 4 out of 5 (81.1%) infants are breastfed immediately after 
birth (38). However, this percentage drops significantly by six months to 51.8%, and only about 
one third (30.7%) of infants are breastfeeding at 12 months (38). At this time, mothers are either 
relying entirely on infant formula or they are supplementing breast milk with formula. The health 
benefits of breastfeeding have long been recognized (39). Evidence suggests human milk 
provides infectious disease protection (11-13), aids in neurodevelopment (14, 15, 39), and 
improves developmental outcomes of premature and low birth weight infants (40). While infant 
formula can never replace breast milk, for mothers that need or choose to use it, it is important to 
narrow the gap between the two in order to ensure proper neonatal nutrition.  
 
2.2.2 Milk components: HM vs. IF 
While infant formula has made tremendous strides in becoming more similar to human milk, 
it is important to note the differences between the two. The composition of human milk is 
influenced by maternal, environmental, and genetic factors, leading it to be quite variable (41). 
The composition of human milk can change within a feeding, diurnally, and over the course of 
lactation in contrast to the standardized compositional range of infant formula (42). It is 
distinctly suited for the infant, in both its nutritional composition and bioactive factors that aid in 
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healthy neonatal development (42). Furthermore, human milk contains active enzymes to 
enhance maturation of the gut and anti-infective properties that protect the newborn from 
infection (43). While human milk is superior to infant formula in many respects, formula can still 
promote efficient growth, development, and nutrient balance of the infant (44).  
 
2.2.3 Human milk oligosaccharides  
Human milk oligosaccharides (HMOs) are the third most abundant solid component of 
breast milk and contain a range of structurally diverse unconjugated glycans (17). One liter of 
mature human milk contains 10-15 g HMO, and concentrations in colostrum (the first milk 
released from the breast) are even more abundant (45). While over 200 HMOs have been 
identified, their composition varies from person to person and throughout the course of lactation 
(46). HMO patterns in breast milk depend on the genetic background of the mother, i.e., on the 
Lewis blood group and secretor status (47). Once ingested by the infant, HMOs withstand the 
low pH of the gut and resist degradation by pancreatic enzymes (48). Thus, intact HMOs pass 
through the distal ileum and serve as nutrients for colonic bacteria.  
Originally, HMOs were thought to promote the health outcome of the neonate by serving 
as a prebiotic that feeds the beneficial bacteria of the gut (17). However, a growing body of 
evidence suggests HMOs are more than just “food for bugs.” Many bacterial, viral, and even 
protozoan pathogens need to adhere to mucosal surfaces to invade and cause disease. Some 
HMOs serve as soluble decoy receptors by resembling mucosal cell surface glycans to prevent 
pathogen binding (17). Furthermore, HMOs have been associated with other biological processes 
including anti-inflammatory properties, prevention of necrotizing enterocolitis, and enhancement 
of brain development (49).  Sialylated HMOs have been identified as modulators of anxious 
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behavior (50), while fucosylated HMOs have been linked to enhancing learning and memory in 
rodents (21-23).  
 
2.3 2ʹ-FUCOSYLLACTOSE  
2.3.1 Metabolism and function 
2ʹ-fucosyllactose (2ʹFL) is the most abundant HMO in human milk with a concentration 
of up to 4.65 g/L (49). The fucosylation of HMOs is determined by the mother’s histo-blood 
group antigen status, particularly the Secretor and Lewis groups (51). It is synthesized in vivo by 
a fucosylation reaction catalyzed by α-(1,2)-fucosyltransferase (FucT2) using GDP-L-fucose as a 
fucose donor substrate to lactose (52). The addition of the monosaccharide, fucose, to lactose 
renders the resulting trisaccharide resistant to digestion by human enzymes (20). This allows 
2ʹFL to gain access to the colon where it can either by fermented by resident bacteria or excreted 
in the feces. Recent research has also shown the detection of 2ʹFL in the urine and plasma of 
both breast-fed infants and those fed formula supplemented with 2ʹFL (51, 53). This suggests 
that 2ʹFL can be absorbed and reach systemic circulation. Over the last decade, researchers have 
begun looking into the metabolic functions of 2ʹFL.  
 
2.3.2 Effect on gut microbiota 
It has been well established that the gut microbiota of the breastfed infant is vastly 
different than those fed infant formula (54-57). Specifically, the microbiome of breast-fed infants 
is often rich in Bifidobacterium species (58). Maternal fucosyltransferase 2 status has been 
shown to affect gut bifidobacteria communities of breastfed infants (59), suggesting a connection 
between 2ʹFL and bifidobacteria.  Bifidobacterium longum subsp. infantis, Bifidobacterium 
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bifidum, and Bifidobacterium breve possess the glycosyl hydrolase fucosidase that metabolize 
2ʹFL (59). This can be beneficial to the infant due to bifidobacteria’s association with protection 
from pathogens, improved immune response to vaccines, and development of the neonatal 
immune system (59). Moreover, a recent study looked at the utilization of 2ʹFL by isolated 
human gut microbes. The results showed that Bifidobacterium spp. and Bacteroides spp. 
exhibited a significant growth increase when 2ʹFL was added to the culture media (60). In 
contrast, 2ʹFL induced minimal growth of Lactobacillus delbrueckii ATCC7830, Enterococcus 
faecalis ATCC19433, and Streptococcus thermophiles ATCC19258. These data illustrate that 
2ʹFL may protect the neonate by enhancing the growth of commensal bacteria while inhibiting 
the growth of pathogens.  
 
2.3.3 Effect on immune development 
Recent research has shown that infants fed formula supplemented with 2ʹFL have an 
immune response similar to those that are breastfed. Using biomarkers of immune function, a 
randomized, double blind clinical study compared 200 babies exclusively breastfed, formula fed 
with 2ʹFL, or formula fed without 2ʹFL (61). The results showed that infants fed formula 
containing 2ʹFL exhibit lower plasma and ex vivo inflammatory cytokine profiles much like 
breastfed babies. Furthermore, 2ʹFL has been shown to suppress CD14 expression and release of 
IL-8 in human enterocytes, reducing inflammation induced by bacterial invasion (62). The 
neonate is vulnerable, particularly to bacterial infection; this finding further illustrates 2ʹFL as an 
important contributor to the infant’s developing immune system.  
2ʹFL has been shown to inhibit binding and infection of several specific enteropathogens 
(63). As their initial step of invasion, many human pathogens bind to mucosal surface receptors 
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that terminate in α1,2-linked fucose (63). This allows 2ʹFL to protect the infant from infection by 
acting as a decoy receptor to competitively inhibit pathogen binding. Moreover, 2ʹFL has been 
shown to have some therapeutic potential in allergy symptomology and immune response. Using 
an ovalbumin-sensitized mouse model of food allergy, the effects of oral treatment with 2ʹFL on 
anaphylactic symptoms were investigated (64). The results from this study showed 2ʹFL 
diminished food allergy symptoms (e.g. diarrhea, hypothermia) and the passive cutaneous 
anaphylaxis response.  
 
2.3.4 Effect on brain and cognitive development   
It has been proposed that HMOs exert positive effects on the brain and cognitive 
development of infants. However, most of the research has focused on sialylated structures, and 
the effects of 2ʹFL need to be further elucidated. In a recent study, 2ʹFL supplementation during 
lactation improved learning and memory in both young and adult rats (22). These cognitive 
functions were assessed by behavioral and electrophysiological measurements right after 
weaning and again during adulthood. While the effects of early-life exposure of 2ʹFL on the 
behavior of young animals were not detectable, there was a benefit to older animals. In a novel 
object recognition task, adult rats fed 2ʹFL during lactation spent significantly longer time 
examining the novel object rather than exploring the familiar one. It is possible that the 
behavioral tests used in this study were not sensitive enough to detect differences in the young 
rats, so an electrophysiological technique (i.e. hippocampal long-term potentiation, LTP) to test 
synaptic function was used. The results showed a positive effect of 2ʹFL on LTP in both youth 
and adulthood.  
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The same group was then interested in understanding if this effect of 2ʹFL on the brain 
was through the gut-brain axis, specifically the vagal nerve (23). Rats were submitted to bilateral 
subdiaphragmatic vagotomy and orally administered 2ʹFL through the diet. The results showed 
that chronic oral administration of 2ʹFL improves LTP, but these effects were inhibited in 
vagotomized rats. Furthermore, rats were trained in Skinner boxes, an operant conditioning task, 
to press a lever to obtain a small pellet of food. While all experimental animals acquired the task, 
the 2ʹFL non-vagotomized rats reached criterion in less sessions than all other groups. They also 
presented a better performance (i.e. higher mean number of lever presses per session) than the 
other three groups. These effects were eliminated by the bilateral vagotomy. This suggests that 
the modulatory effects of 2ʹFL on brain function and cognition could be due to the gut-brain axis, 
but more specifically, the vagal nerve. 
 
2.4 THE PIG AS A MODEL FOR HUMANS  
The neonatal piglet is an emerging model for pediatric biomedical research and often 
used in studies that would be unethical to attempt in humans. Within the last few decades, the pig 
has been utilized to study cardiovascular physiology, obesity, stress, dermatology, immunology, 
behavior, as well as many aspects of nutrition (65). The anatomy and physiology of the digestive 
tract of the pig is much more similar to humans than rodents. In particular, the rodent is a hindgut 
fermenter and relies on cecal fermentation. Like humans, the pig possesses a monogastric 
digestive tract that relies on both cecal and colonic fermentation. Piglet metabolism has been 
extensively studied (66), and thus the abundance of information increases the reliability of the 
piglet as a model for pediatric nutrition. Furthermore, the biology of the pig shows strong 
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similarities with human brain anatomy and perinatal growth patterns (67) making it a useful 
model for studying neurodevelopment in human infants.  
Recently, the neonatal piglet has been established as a model for studying the effects of 
intrauterine growth restriction on neurodevelopment (27). In pigs, IUGR is naturally occurring, 
and is often linked to placental insufficiency and litter size (2). Some “runts” are born almost one 
half to one third the size of their largest littermates (68). For both species, IUGR often leads to 
SGA neonates. Yet, in humans, it is difficult to distinguish the effects of being born SGA from 
being born preterm or low birth weight (LBW). Determining gestational age in humans can be 
challenging (69). However, in swine production, artificial insemination is used, and therefore the 
time of conception is known. Thus, SGA piglets are a useful model for human infants born SGA 
due to IUGR.   
 
2.5 SUMMARY 
Robust growth and expansion of the brain occurs during the last trimester and the first 
year of life (7, 8). The brain is particularly vulnerable during this period, and long-lasting, 
potentially permanent, harm on brain structure and function can occur if these early 
developmental processes are disrupted. One region highly susceptible to stressors during this 
time is the hippocampus, an important brain region involved in learning and memory. 
Intrauterine growth restriction can have a lifelong influence on the neonates potential for 
development and survival. These deficits often persist into adulthood (10), and therefore, it is 
imperative to develop efficacious interventions for reversing or mitigating the cognitive 
impairments associated with being born SGA due to IUGR. Human milk is commonly referred 
to as the “gold standard” of infant nutrition for it contains all of the essential nutrients for the 
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growth and development of the infant. While infant formula can never replace breast milk, for 
mothers that need or choose to use it, it is important to narrow the gap between the two in order 














































3.1 ANIMALS, HOUSING, AND DIETS 
Sex-matched, littermate pairs of naturally farrowed piglets (AGA, 1.3-1.8kg; SGA, 0.5-
0.9kg) were obtained from the University of Illinois swine herd. Piglets were transported to the 
biomedical animal facility 48 h after birth (to allow for adequate colostrum intake) and received 
an intramuscular injection of iron dextran (100mg; Henry Schein, Dublin, OH, USA) and a 
broad-spectrum antibiotic (Gentamicin Piglet Injection, 5mg; AgriLabs, St. Joseph, MO, USA), 
which is standard industry practice for animals of this age. The piglets were individually housed 
in clear, acrylic-sided cages (0.75 m long X 0.58 m wide X 0.47 m high), as previously described 
(70, 71). Each cage was positioned in a rack and fitted with flooring designed for neonatal 
animals (Tenderfoot/NS®, Tandem Products, Inc., Minneapolis, MN, USA) to separate them 
from their excrement. A cotton towel and toy (plastic Jingle Ball™, Bio-Serv, Frenchtown, NJ, 
USA) were provided for enrichment. Room temperature was maintained at 27°C and radiant 
heaters located directly above piglets provided supplemental heat. A 12-h light/dark cycle was 
maintained; however, minimal lighting was provided during dark cycle.  
Piglets were assigned to 4 treatment groups controlling for body weight (BW), sex, and 
litter of origin (n = 9 per group): Control-AGA, Control-SGA, 2ʹFL-AGA, and 2ʹFL-SGA. 
Piglets were fed a nutritionally adequate milk replacer diet (Advance Liqui-Wean, Milk 
Specialties Co., Dundee, IL, USA) upon arrival at the animal care facility. Milk was 
reconstituted each morning to a final concentration of 206 g/L using tap water and fed at a rate of 
300 ml/kg body weight (based on daily recorded weights).  2ʹFL was orally administered through 
the diet at a concentration of 1.17 g/L. The dose of 2ʹFL was calculated so that piglets received 
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approximately 350 mg 2ʹFL/kg of body weight (BW) per day. This is roughly equivalent to the 
average dose a breast fed infant would receive. No extra water was provided other than that used 
in milk replacer. Meals were provided in bowls located in the home cage after cognitive testing 
and every 3 h thereafter. Piglets were fasted for a 10-h period prior to the start of cognitive 
testing to ensure motivation for milk rewards used in task. All animal care and experimental 
procedures were in accordance with the National Research Council Guide for the Care and Use 
of Laboratory Animals and approved by the University of Illinois at Urbana-Champaign 
Institutional Animal Care and Use Committee.  
 
3.2 COGNITIVE TESTING  
 Piglet spatial learning and memory was assessed using a clear plastic plus-shaped maze 
(double T-maze) with extra-maze visual cues, as previously described and validated (72). The 
maze consisted of 2 start arms (north and south) and 2 reward arms (east and west). Start arm 
location was randomized throughout testing to force piglets to rely on a hippocampal-dependent 
allocentric mechanism (i.e. create spatial map of room using extra-maze visual cues) instead of a 
striatum-dependent egocentric mechanism (i.e. turn body left or right) for solving the task (73). 
Starting on postnatal day (PD) 14, piglets were tested each morning between 08:00 h and 12:00 h 
by one trained experimenter following overnight food deprivation. Testing consisted of 10 trials 
per day (60 s per trial) for 10 days. The first 6 days involved the acquisition phase of testing, 
where piglets learned to locate the chocolate milk reward (3 ml of control milk replacer used for 
daily feedings with addition of Nesquik cocoa powder, supplied according to manufacturer’s 
directions) in a constant place and direction (e.g., east reward arm). To balance for olfactory 
cues, chocolate milk was provided in both reward arms, but was only accessible in the correct 
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arm. This was followed by 4 days of the reversal phase, where the previously incorrect arm (e.g., 
west reward arm) was now rewarded. A learning criterion of 80% correct was established for 
both the acquisition and reversal phases of testing. Piglet movement within the maze was tracked 
live using commercially available software (EthoVision 3.1; Noldus Information Technology 
Inc., Leesburg, VA, USA) by a camera mounted from the ceiling above the arena.  
 
3.3 MAGNETIC RESONANCE IMAGING   
 On PD 28, piglets were transported to the Biomedical Imaging Center at the Beckman 
Institute and anesthetized using a telazol:ketamine:xylazine solution (100/50/50 mg/kg/BW; Fort 
Dodge Animal Health, Overland Park, KS, USA). The anesthetic combination was administered 
intramuscularly at 0.022 ml/kg BW and anesthesia was maintained throughout the scan by 
inhalation of isoflurane (98% oxygen/2% isoflurane; Henry Schein, Dublin, OH, USA). Once 
fully anesthetized, piglets were restrained to prevent motion artifacts and placed in the MRI 
scanner. Vital signs were monitored and recorded every 5 minutes throughout the scanning 
procedure using an MRI compatible pulse oximeter.  
 All MRI was conducted using a Siemens MAGNETOM Trio 3T imager and a 32-channel 
head coil (Siemens, Erlangen, Germany). Anatomic images were acquired using a 3D T1-
weighted, magnetization-prepared rapid gradient-echo (T1 MPRAGE) sequence with the 
following parameters: repetition time = 1,900 ms, echo time = 2.49 ms, inversion time = 900ms, 
flip angle = 9°, matrix = 256x256, 224 slices with slice thickness = 0.7 mm. The final voxel size 
was 0.7 mm isotropic across the entire head from the tip of the snout to the cervical/thoracic 
spinal cord junction, as previously described (74). All methods used for voxel-based 
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morphometry (VBM), brain region volume estimation analysis, diffusion tensor imaging (DTI), 
and brain metabolites were performed as previously described (27). 
3.4 RNA-SEQUENCING ANALYSIS  
3.4.1 RNA Extraction, cDNA synthesis, and RNA-Sequencing Library Preparation 
An independent cohort of neonatal piglets (n = 24) was used to analyze the effects of 
SGA and 2ʹFL on gene expression patterns in the hippocampal transcriptome. Piglets were 
treated the same as those used for cognitive testing and MRI, but on PD14 piglets were 
euthanized and right hippocampi were dissected, snap frozen, and stored at -80°C until RNA 
could be extracted. Tissue (~50mg) was thawed and homogenized in 1 mL TRIzol Reagent 
(ThermoFisher Scientific, Waltham, MA, USA), followed by centrifugation for 10 minutes at 
12,000xg at 4°C. The supernatant was then moved to fresh tubes. Chloroform (0.2 mL) was 
added and vortexed for 10 seconds, incubated at room temperature for 5 minutes, and then 
centrifuged at 10,000xg for 18 minutes at 4°C. The clear supernatant was then moved to new 
tubes before 0.4 mL of 200 proof ethanol was added and the samples were vortexed. After, the 
samples were loaded into RNeasy Mini Kit columns (cat. No. 74104, Qiagen, Germantown, MD, 
USA) following the manufacturer’s protocols beginning at Part 1 step 3. An RNase-free DNase 
set (cat. No. 79254, Qiagen, Germantown, MD, USA) was used for on-column DNase digestion 
to remove genomic DNA following the manufacturer’s protocol. A NanoDrop 
Spectrophotometer (NanoDrop Technologies, Inc.) was used to determine RNA concentrations.  
Samples were analyzed by the Carver High-Throughput DNA Sequencing and 
Genotyping Unit (HTS lab, University of Illinois, Urbana, IL, USA) using AATI Fragment 
Analyzer (Advanced Analytical Technologies, Inc.) to determine RNA integrity and the 
presence/absence of genomic DNA. Only RNA samples with RNA integrity number (RIN) 
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greater than 7 were used for sequencing. Ribosomal RNA was removed using a Ribozero Kit 
(Illumina Inc., San Diego, CA, USA) and TruSeq Stranded RNA-seq libraries were created using 
the TruSeq Stranded RNA Sample Preparation Kit (Illumina Inc., San Diego, CA, USA) 
following standard protocols on the HiSeq 4000 in four lanes with single-reads 100nt in length. 
The pool produced over 1.5 billion reads with average quality scores above 30 from start to 
finish. The libraries were quantified by qPCR and sequenced on four lanes for 101 cycles from 
one end of the fragments on a HiSeq 4000 using a HiSeq 4000 sequencing kit version 1. Fastq 
files were generated and demultiplexed with bcl2fastq v2.17.1.14 Conversion Software (Illumina 
Inc., San Diego, CA, USA).  
 
3.4.2 Obtaining Gene Counts for RNA-Sequencing Analysis 
The 24 libraries were transferred from the HTS lab to the High-Performance Biological 
Computing Lab (HPCBio, University of Illinois, Urbana, IL, USA) to obtain gene counts. Data 
were transferred to the Biocluster using Globus and then decompressed. The Sus scrofa 10.2 
reference genome files were obtained from NCBI annotation release 105. The annotation file was 
then converted to GTF format for compatibility with STAR (version 2.5.2a), an alignment 
software. A quality check was performed on the FASTQ files using FASTQC (version 0.11.5) 
software. The reads had already been adapter trimmed at the HTS lab. Results were collated 
using MultiQC (version 0.7), and the quality of reads was excellent. Trimmomatic (version 0.33) 
was used to trim any residual adapter content and low quality bases. Very few reads were lost 
due to trimming. A quality check was performed on the trimmed FASTQ files using FASTQC 
(version 0.11.5) software. These were run in the same way as the raw reads. The results were 
nearly identical to the raw reads, since relatively few reads were trimmed. Alignments were ran 
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against the Sus scrofa genome using STAR software, and approximately 80% of reads aligned. 
All gene counts were generated using featureCounts in the subread (version 1.5.0) package. Only 
uniquely aligned reads are considered in featureCounts, and results were collated with MultiQC 
(version 0.7). Approximately 20% of aligned reads were assigned to a gene. This percentage is 
quite low and may be due to the quality of the available Sus scrofa genome annotation file. It is 
likely not a very complete annotation file. This is evidenced by the fact that many reads (~ 50%) 
were assigned to “no features”, which means they aligned to the genome but did not align to a 
known gene 
 
3.4.3 RNA-sequencing Read Fates 
All analyses hereafter were done in R (75; v 3.3.2). Only 20.2% to 22.7% of the total 
reads ended up aligning uniquely within genes, while 56.5% to 59.7% did align uniquely, but not 
within exonic regions of known genes. Further investigation showed this was not due to DNA 
contamination or widespread missing gene annotations for Sus scrofa. One sample was checked 
and found to have a further 25% of reads aligning within intronic regions of known genes. 
Immature, pre-spliced RNAs are abundant in human fetal brain tissue (76), so it is likely these 
neonatal pig brain samples also have a high abundance of immature RNAs. These immature 
RNAs would have been sequenced because ribosomal depletion was used instead of polyA 
selection when making sequencing libraries. Although only ~21.5% of reads aligned uniquely 
within genes, this resulted in ~13.63 million reads per sample. There was no correlation between 
sequencing depth and number of genes with at least one read (Pearson correlation coefficient = 
0.025), thus, the sequencing depth was sufficient. The numbers of reads per gene were 
normalized using TMM normalization (77) in the edgeR package (78).  
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3.4.4 Filtering no/low Expressed Genes  
NCBI's Sus scrofa 10.2 genome has a total of 38,878 genes in annotation release 105. 
Often a large percentage of genes are not expressed in the sequenced samples and can be 
removed to reduce the penalty for testing large numbers of genes. However, what number of 
reads constitutes real expression is unknown because sequencing errors can lead to false 
alignments. A standard metric is to consider ~10 read counts per sample, adjusted for sequencing 
depth, in one or more samples as the threshold. Therefore, a requirement of 1 count per million 
(after TMM normalization) in at least 3 samples was established to keep a gene. 18,968 genes 
did not meet this threshold and were filtered out, leaving 19,910 genes to be analyzed for 
differential expression. 
3.4.5 Overall Clustering of Samples and Estimation of Surrogate Variables 
Samples were clustered after normalization to find outliers, overall treatment differences, 
or batch effects. Surrogate variables analysis (79, 80) was used to remove artifacts from the 
dataset by estimating surrogate variables (SV) corresponding to covariance structures found that 
were not due to our variables of interest (i.e. size and diet) or the batch effect of sex. Five SV 
were found, the first two of which corresponded not only to cohort, but to differences between 
pairs within cohorts, SV3 corrects mainly for difference in a single sample, while SV4 and SV5 
appear to correct for additional individual sample and pair effects. The SV can be added to the 
statistical model to adjust for their effects when calculating differential expression, and can also 






3.4.6 Gene-level Statistical Analysis and Functional Annotation 
Testing for differential expression was done using the limma package's (81) empirical 
Bayes method (82) for RNASeq data known as the "voom" method, which transforms the count 
data appropriately for linear modeling using log2[(count + 0.5) / (library size x TMM norm 
factor + 1) / 1e6))] and also estimates observational (gene) -level weights (83), which adjust for 
the calculated mean-variance relationship. The seven different contrasts were pulled from the 
model: the main effects of size and diet, the interaction term and the four logical pairwise 
comparisons. Multiple hypothesis testing adjustment using the False Discovery Rate (FDR) 
method (84) was done globally across all seven contrasts together, so that the same raw p-value 
ended up with the same FDR p-value in all contrasts. 
Function annotation information for each gene was pulled from two sources. 
Bioconductor's (85) org.Ss.eg.db package (86) was used to get Gene Ontology's Biological 
Process, Cellular Component and Molecular Function terms for Sus scrofa genes. Updated 
KEGG pathways, matched based on Entrez Gene IDs, were pulled directly from KEGG using the 
KEGGREST package (87). 
3.5 BRAIN WEIGHT 
After MRI was complete, anesthesia was maintained with 0.5 mL 
telazol:ketamine:xylazine solution and piglets were euthanized by intracardiac injection of 1 mL 
sodium pentobarbital (Fatal Plus, 72mg/kg body weight; Vortech Pharmaceuticals, Dearborn, 





3.6 STATISTICAL ANALYSIS 
3.6.1 Weight gain, brain weight, and cognitive testing 
Data analysis for weight gain and cognitive testing were conducted using the MIXED 
procedure of the SAS 9.4 software (SAS Institute, Cary, NC, USA) as a 3-way (size x diet x day) 
repeated measures ANOVA. Brain weight was analyzed as a 2-way (size x diet) ANOVA using 
GraphPad Prism 7. Measures that were not significant (i.e. sex, litter, cohort) were removed from 
the model for all analyses. Significant difference was declared at p<0.05, tendency at p<0.10. 
Data are presented as average ± SEM.  
 
3.6.2 Voxel-Based Morphometry 
The statistical parametric mapping (SPM) toolbox was used for statistical analysis. A 2-
way ANOVA with main effects of size (AGA vs. SGA) and diet (2ʹFL vs. CON) was performed, 
no covariates were used, and an ANCOVA was used for global normalization. Pseudo-T 
statistical maps were generated showing areas where there was a difference (i.e. reduction) in 
grey or white matter for all comparisons using an uncorrected p<0.001. A threshold of at least 20 
edge-connected voxels (clusters) was used.  
 
3.6.3 Brain Region Volume Estimation, DTI, and MR-Spectroscopy 
Data analysis was conducted as a 2-way (size x diet) ANOVA using GraphPad Prism 7. 
For individual brain region volume estimation, brain volumes were expressed as absolute (mm3) 
or relative (i.e. as a proportion of total brain volume for each piglet) units. No covariates were 









4.1 BRAIN AND BODY WEIGHTS  
AGA piglets were born with an average body weight of 1.45±0.12 kg and SGA piglets 
were born with an average body weight of 0.82±0.10 kg (p<0.05). The average body weights of 
AGA and SGA piglets were significantly different (p<0.05) throughout the study, with no effect 
of diet (Figure 1). At PD 28, AGA piglets had larger brain weights than SGA piglets (48.96 g 
and 44.85 g, respectively; p=0.003). However, the brain to body weight ratio was greater in SGA 
piglets compared to AGA piglets (p<0.0001) suggesting a ‘brain-sparing’ effect during IUGR in 
SGA piglets (Figure 2). There was no effect of diet on brain or brain to BW ratio of piglets.  
 
4.2 COGNITIVE TESTING 
During the acquisition phase of testing, overall piglet performance in the spatial T-maze 
task improved over time (p<0.0001) and SGA piglets made fewer incorrect choices than AGA 
piglets (p < 0.05; Figure 3). The size x day interaction was not significant (p>0.05). There was a 
trend for significance of diet (p=0.051) such that control piglets made fewer incorrect choices 
than 2ʹFL, but the diet x day interaction was not significant (p=0.192).  
There were no significant interactions or main effects observed during the reversal phase 






4.3 MAGNETIC RESONANCE IMAGING 
4.3.1 Brain Volume Estimation 
Piglet brain volume was affected by birth weight, but not dietary intervention. A main 
effect of size was observed for total brain volume, where SGA piglets had smaller (p<0.001) 
total brain volumes than their AGA counterparts (Figure 4). When absolute brain regions of 
interest (ROI) values were evaluated, a main effect of size was observed for 12 of 22 ROI, where 
SGA piglets had smaller (p<0.05) volumes as compared to AGA piglets. There was no effect of 
2ʹFL on total brain volume or the 22 ROI evaluated (Table 1).   
Due to different overall brain volumes of AGA and SGA piglets, relative brain volumes 
were compared (Table 2). Again, no main effect of 2ʹFL was observed for any ROI. Yet, a main 
effect of size was observed such that SGA piglets had smaller relative volumes of the 
hypothalamus (p=0.034), internal capsule (p=0.002), lateral ventricle (p=0.030), midbrain 
(p=0.001), pons (p<0.001), putamen (p<0.001), thalamus (p=0.011), and white matter (p=0.045) 
than AGA piglets.  
 
4.3.2 Voxel-Based Morphometry 
Volumetric differences were revealed in absolute grey matter (GM), but not absolute 
white matter (WM), between treatment groups using voxel-based morphometry (Table 3). A 
comparison of grey matter concentration in which AGA piglets had higher (p<0.001) regional 
peak intensities compared to SGA piglets (AGA > SGA) displayed differences in the left and 
right cortices, thalamus, cerebellum, left hippocampus, and midbrain. Analyzing regional 
clusters revealed a main effect of diet in the right cortex, such that GM in CON piglets was more 
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concentrated than 2ʹFL piglets (p<0.001) as defined by significant peak intensities. This voxel 
wise comparison displayed no significant interactions or main effects in WM concentration.  
 
4.3.3 Single-Voxel Spectroscopy 
Total metabolite concentrations of N-acetylaspartate + N-acetylaspartylglutamate  
(NAA + NAAG), glutamate + glutamine (Glu + Gln), glycerophosphocholine + phosphocholine 
(GPC + PCh), creatine + phosphocreatine (Cr + PCr), myo-inositol, and lactate were measured in 
the hippocampus of AGA and SGA piglets fed control and 2ʹFL (Table 5). Data were excluded 
from the analysis if the standard deviation percentage exceeded 20%. Myo-inositol and lactate 
did not meet criteria for analysis and were not included. There were no significant interactions or 
main effects for any of the metabolites measured. 
 
4.3.4 Diffusion Tensor Imaging 
Assessment of cortical white matter, corpus callosum, caudate, internal capsule, 
thalamus, and both hippocampi was performed using diffusion tensor imaging (DTI; Table 4). 
Analysis of DTI data revealed a main effect of size such that SGA piglets had a significant 
decrease in fractional anisotropy (FA) within caudate (p=0.006), internal capsule (p=0.037), right 
hemisphere white matter (p=0.002), total white matter (p=0.002), and whole brain (p=0.002). No 
brain regions exhibited significant differences in FA values due to 2ʹFL supplementation.  
Additionally, there were differences observed between SGA and AGA piglets in the 
caudate in terms of mean diffusivity (p=0.015), radial diffusivity (p=0.011), and axial diffusivity 
(p=0.024). No other brain regions exhibited significant interactions or main effects for these 
measures. 
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4.4 RNA-SEQUENCING ANALYSIS 
Overall, 529 differentially expressed genes (DEGs) were revealed in hippocampal tissue 
obtained from piglets on PD14 (p<0.006; Figure 5). A total of 115 DEGs were identified in 
response to size, of which 62 were up-regulated and 53 were down-regulated in SGA piglets 
compared to AGA piglets. A main effect of diet revealed 252 DEGs, of which 144 up-regulated 
and 108 down-regulated genes in 2ʹFL piglets compared to CON. There was an interaction 
among 162 genes where 73 were up-regulated and 89 were down-regulated. The Database for 
Annotation, Visualization, and Integrated Discovery (DAVID v6.8; 88, 89) tool was used for 
functional enrichment analysis.  
DAVID utilizes Gene Ontology (GO) classifications to understand the trends in 
transcriptional response between each main effect and the interaction term (90). This system 
characterizes genes using defined categories of molecular function (MF), biological process 
(BP), and cellular component (CC). Only annotation clusters with enrichment scores >1.3 were 
included in the analysis. The GO categories for up-regulated genes between the SGA and AGA 
groups were associated with chromatin silencing, DNA binding, nuclear chromatin, and the 
nucleosome. Interestingly, down-regulated genes between SGA and AGA groups were 
associated with KEGG pathways for measles, influenza A, hepatitis C, and herpes simplex 
infection. Moreover, genes that were up-regulated in response to 2ʹFL were connected to integral 
components of membranes and transmembrane helix, while down-regulated genes were clustered 
based on ion channel and transport, zinc ion binding, zinc-finger, and metal-binding. Finally, in 
the size by diet interaction, there were no clusters discovered as a result of up-regulated gene 
expression, however, down-regulated genes were associated with transmembrane helix, 




DISCUSSION AND CONCLUSIONS 
 
Intrauterine growth restriction often leads to small for gestational neonates, increasing 
risk of cognitive impairments and learning deficits that persist into adulthood. Rapid growth and 
expansion of the brain occurs during the last trimester and the first year of life leaving it 
vulnerable to insults that may be mitigated with proper early-life nutrition. The benefits of 
breastfeeding have been well established and many studies have validated the positive impact of 
human milk on the cognitive development of neonates. While exclusive breastfeeding rates 
continue to rise, numerous mothers rely on infant formula. While formula can promote efficient 
growth, development, and nutrient balance of the infant (44), there are functional ingredients that 
it lacks leading human milk to be far superior. Therefore, it is imperative to develop products 
that close the gap between the two in order to ensure proper neonatal nutrition.  
Due to their abundance in human milk, HMOs have become a major target for improving 
formula. It has been postulated that HMOs play a key role in brain development due to their high 
abundance and variety as compared to bovine-milk based formulas (17). Yet, with over 200 
identified, it is not economical or practical for infant formula to contain the full repertoire of 
HMOs. Thus, by identifying the key HMOs in breast milk, it is possible that the brain 
development of infants fed formula can be more similar to that of the breastfed neonate. Recent 
studies have demonstrated 2ʹFL, the most abundant HMO, enhances brain and cognitive 
development (21-23). To our knowledge, there has been no published data investigating the 
effect of dietary 2ʹFL on the brain and cognitive development of SGA infants. Therefore, the 
present study utilized a neonatal piglet model to determine if orally administered 2ʹFL could 
enhance brain and cognitive development in infants born SGA due to IUGR.  
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Piglet learning and memory was tested using a hippocampal dependent spatial T-maze 
task. Chocolate milk was present in both reward arms to balance for olfactory cues, and the start 
arm location was randomized throughout testing. Thus, piglets were forced to rely on extra-maze 
visual cues to create a spatial map (i.e. allocentric mechanism) instead of a striatum-dependent 
egocentric mechanism (i.e. turning body left or right) for solving the task (28). Our group has 
previously reported a learning deficit in SGA piglets using the spatial T-maze task, whereby 
SGA piglets required several additional days to reach criterion as well as made more errors than 
AGA piglets (27). Interestingly, in the present study SGA piglets reached criterion faster as well 
as made fewer errors than their AGA counterparts. However, there are important differences to 
note between the experimental designs of these studies. In the former study, piglets were 
supplied milk replacer at 285 ml/kg BW while piglets in our present study were fed at 300 ml/kg. 
Furthermore, an automated milk delivery system was utilized in our previous study, whereby 
piglets were fed their daily-allotted milk over 18 meals (once per hour) followed by a 6-h fasting 
period prior to behavioral testing. The present study supplied 5 meals (once every 3 hours) per 
day followed by a 10-h fasting period prior to behavior testing. In the prior study, the overall 
body weights of AGA and SGA piglets were lower than those in the present study, and the SGA 
piglets experienced compensatory “catch up” growth such that the average weight of SGA and 
AGA piglets was similar by PD 15 and throughout behavioral testing. In the present study, AGA 
and SGA final body weights were significantly different, with no effect of 2ʹFL, throughout the 
study. Moreover, in the present study, the brain weights were significantly different between 
SGA and AGA piglets on PD 28, while the brain weights in the prior study were not different. 
The differences identified between the two studies must be considered when comparing their 
results.  
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Performance of SGA piglets in the spatial T-maze task was opposite to what we expected 
and differs from results in human studies. Yet, Antonides et al. (91) found similar results when 
evaluating cognitive performance of very low birth weight (VLBW) piglets. Using a holeboard 
task to test spatial learning and memory, they found that VLBW piglets acquired the task faster 
and reached a higher performance level than normal birth weight piglets. Taken together, our 
results could be the outcome of a compensatory mechanism developed in utero to increase piglet 
survivability. Furthermore, it is possible that SGA piglets are more strongly motivated to obtain a 
food reward than AGAs. Further research is needed to measure food motivation and cognitive 
compensatory mechanisms in SGA piglets.  
In the present study, 2ʹFL did not enhance neonatal piglet performance in the spatial T-
maze task. Oliveros et al. (22) found similar results utilizing a novel object recognition task for 
young and adult rats. In this study, there were no differences found between 2ʹFL and CON 
groups in young rats, but adult 2ʹFL rats spent more time exploring novel objects than the CON 
animals did. It is possible that the 2ʹFL supports a long-term cognitive effect, and the animals 
utilized in the present study were too young to observe a performance difference. Moreover, it is 
possible that the spatial T-maze is not a sensitive enough behavioral task to identify the benefits 
of 2ʹFL. Vazquez et al. (21) utilized hippocampal long-term potentiation (LTP) to understand the 
role of 2ʹFL on gut-brain communication. LTP is an electrophysiological technique that has been 
considered a key cellular mechanism underlying learning and memory processes. Better learning 
skills would be reflected in higher and longer-lasting LTP. To our knowledge, LTP has yet to be 
utilized in the neonatal piglet model, but it could shed light on the role of 2ʹFL on the SGA brain.  
For SGA human infants, catch-up growth is common and typically associated with 
decreased mortality within the first few months after birth (92). It has also been connected with a 
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lowered risk of neurologic and intellectual dysfunction in early adulthood (93). Yet, catch-up 
growth is not commonly seen in the swine industry. When grown out to slaughter age, low birth 
weight pigs showed the lowest growth performance and lean percentage compared to normal 
birth weight pigs (94). This is consistent with our data, such that SGA piglets never experienced 
catch-up growth and remained significantly smaller than their AGA counterparts throughout the 
entire course of the study. It’s important to note that our piglets were limit fed, which may have 
prevented them from demonstrating catch-up growth. 2ʹFL had no effect on piglet growth 
throughout the study. However, this is consistent with other studies orally administering 2ʹFL. A 
3-week pre-clinical study in farm piglets observed no growth and developmental effects of 
various concentrations of 2ʹFL (95). In this study, male and female piglets fed 2ʹFL showed 
consistent increase in BW over time when compared to control piglets. This could also explain 
the lack of brain growth and maturation seen from the MRI analysis as well.  
In the present study, the assessment of total brain volume revealed SGA piglets had 
significantly smaller brains at PD 28. However, the brain to BW ratio of SGA piglets was much 
larger than that of AGA piglets, suggesting a “brain-sparing” effect. The most common cause of 
IUGR is placental insufficiency, and this often results with the fetus adapting its circulation to 
preserve oxygen and nutrient supply to the brain (96). The brain-sparing effect is implemented as 
a protective mechanism, yet several studies have shown that IUGR subjects with brain-sparing 
display worse neurodevelopmental and behavioral outcomes when compared to symmetric IUGR 
and controls (96). Prolonged brain-sparing, such as that seen in the present study, may lead to 
altered structure and function of the cerebral vasculature.  
Absolute volumetric assessment of specific brain regions revealed 12 significantly 
smaller regions in SGA piglets as compared to AGA piglets, with no effect of 2ʹFL. Yet, when 
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these regions were expressed relative to total brain volume, only the midbrain, pons, and 
thalamus were still affected by SGA status. Interestingly, the hypothalamus, internal capsule, and 
lateral ventricle of SGA piglets were significantly smaller than AGA piglets when expressed 
relative to total brain volume. These regions were not significant as a result of the absolute 
volumetric assessment. Taken together, these results suggest SGA neonates have proportionately 
smaller subcortical structures, giving reason to believe there is preferential development of these 
regions as a result of IUGR.  
VBM grey matter (GM) outcomes support this idea of preferential development of 
subcortical regions. AGA piglets exhibit higher GM volume percentages in the cerebellum, 
thalamus, hippocampus, and midbrain when compared to SGA piglets, suggesting these regions 
are more mature in AGA neonates. While VBM did not reveal any volumetric WM differences, 
diffusion tensor imaging (DTI) was utilized to evaluate WM maturation in piglet brains. DTI 
sequences allow for interpretation of water movement within the brain. As the composition and 
morphology of the brain changes over time, the movement of water is also expected to change 
reflecting the development and maturation of WM tracts. WM tract development is the most 
intense during the perinatal period, but begins during the prenatal period and continues through 
adulthood (97). SGA neonates have been connected to a reduction in WM integrity and increase 
in prevalence of psychiatric symptoms in adulthood (98). In the present study, there was reduced 
fractional anisotropy (FA) in the caudate, internal capsule, whole brain, right hemisphere white 
matter, and total white matter of SGA piglets. This reduction in FA typically represents damaged 
or reduced organization of WM bundles, and it is often connected to axon injury or reductions in 
myelination (98). This suggests that SGA neonates have microstructural deficits in these brain 
regions that are likely caused by reduced number of axons and myelination. 
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Aside from FA, there are three other outcome measurements obtained from DTI 
sequences. Mean diffusivity (MD) measures the total water movement within a specific region, 
radial diffusivity (RD) measures water movement perpendicular to axonal alignment, and axial 
diffusivity (AD) is utilized to measure the movement of water parallel to axonal alignment. 
There was no effect of 2ʹFL, but SGA piglets had an increase in MD, RD, and AD in the caudate 
when compared to AGA piglets. This finding is not surprising because AGA piglets had 
significantly larger brain volumes than SGA piglets and MD typically decreases as brain 
microstructure increases in size (99). As axons mature, they become wrapped in myelin. This 
results in decreased RD and AD values as less water is able to move across the axon. Thus, a 
higher RD or AD would be indicative of less myelination. The caudate nuclei are an essential 
part of the brain’s learning and memory system. However, research has shown a modulatory role 
of the caudate in the processing of egocentric spatial cues and not allocentric spatial cues (100), 
as seen in the spatial T-maze task. Therefore, further tests are needed to understand if there are 
any behavioral modifications associated with the microstructural deficits in the caudate of SGA 
neonates.  
MRS did not reveal any significant interactions or main effects in hippocampal 
metabolites in the present study. This is consistent with data in our previous study comparing 
SGA and AGA neonatal piglets (27), and it is important to note that Roelants-van Rijn et al. 
(101) discovered similar brain metabolite concentrations between SGA and AGA preterm human 
infants 
Due to the limited knowledge of the influence of 2ʹFL on learning and memory in SGA 
neonates, we utilized RNA-sequencing technology to identify global differences in hippocampal 
gene transcription. The gene ontology and pathway analysis suggested that the differentially 
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expressed genes due to size, most of which were up-regulated in SGA compared to AGA, were 
associated with chromatin silencing, DNA binding, nuclear chromatin, histone core, and the 
nucleosome. DNA and histones are the basic components of a chromosome. Recent studies have 
shown that the regulation of higher-order chromatin structures by DNA methylation and histone 
modification is critical for genome reprogramming en utero, and for tissue-specific gene 
expression and global gene silencing (102). If chromatin modification is disrupted, it can lead to 
the dysregulation of developmental processes and various diseases. Further research is needed to 
understand the role of epigenetics and IUGR.  
Interestingly, down-regulated genes between SGA and AGA groups were associated with 
KEGG pathways for measles, influenza A, hepatitis C, and herpes simplex infection. However, 
the same 4 genes were clustered into these annotation categories: DExD/H-box helicase 58 
(DDX58), adenosine deaminase (ADAR), interferon regulatory factor 9 (IRF9), and interferon-
induced double-stranded RNA-activated protein kinase. DDX58 is involved in the innate 
immune defense against viruses while ADAR is a protein-coding gene that has shown to increase 
gene product diversity (103). Further research is needed to elucidate the effect of down-
regulating these genes in IUGR neonates.  
To our knowledge, there is no published data on the effect of 2ʹFL on the hippocampal 
transcriptome. Genes that were up-regulated in response to 2ʹFL were connected to integral 
components of membranes and transmembrane helix, while down-regulated genes were clustered 
based on ion channel and transport, zinc ion binding, zinc-finger, and metal-binding. Taken 
together, it appears that 2ʹFL modulates channels and membranes, possibly permitting or 
reducing the transport of substances across the biological membrane.  
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In the size by diet interaction, there were no clusters discovered as a result of up-
regulated gene expression, however, down-regulated genes were associated with transmembrane 
helix, membranes, and integral components of membrane. It seems that both 2ʹFL and SGA 
modulate the epigenome, but again, further research is necessary to understand pathophysiology 
of these epigenetic changes. 
 In conclusion, the present study found that the volumetric and microstructural deficits 
observed in SGA piglets did not influence spatial learning and memory. While we found no 
evidence that 2ʹFL affected brain structure or behavior, it modified the expression of genes 
associated with membranes, transporters, and ion channels in hippocampal tissue. Further study 
is needed to assess if this differential gene expression is beneficial to the SGA neonate. 
Nonetheless, the present study suggests 2ʹFL can be provided to vulnerable IUGR neonates 
without adversely affecting growth and brain development.  This is important because the most 





















There are many possible directions to take in order to enhance our understanding of the 
role of 2ʹFL on learning and memory in SGA neonates. Since no differences were found using 
the spatial T-maze task between PD 14 and 24, a later time point could be used to see if there are 
long-term benefits of consuming 2ʹFL during the postnatal period. Furthermore, a more sensitive 
measurement of learning and memory could be utilized instead of the spatial T-maze task. It is 
possible that the beneficial effects of 2ʹFL were so subtle that the T-maze didn’t reveal them, 
thus a more sensitive measurement (e.g. LTP) could be utilized to elucidate a role of 2ʹFL in 
learning and memory. Moreover, it is possible that SGA piglets developed a compensatory 
mechanism in utero that programmed them to be more motivated by a food reward. Other 
behavioral tests, such as novel object recognition, could remove this potentially confounding 
factor.  
While there was no effect of SGA on spatial learning and memory, DTI results indicate 
that there was less myelination in the caudate nucleus. The caudate has shown a modulatory role 
in egocentric learning and memory (100), and further research could identify if SGA neonates 
have deficits in striatum-dependent learning. 2ʹFL may be used as an intervention to attenuate 
these deficits if they exist.   
Finally, the RNA-sequencing data suggest that there are epigenetic modifications that 
result from IUGR. Epigenetics involve changing gene expression without changing the 
underlying DNA sequence. DNA methylation and histone modifications (i.e. acetylation, 
methylation, phosphorylation) are types of epigenetic mechanisms that alter DNA accessibility 
and chromatin structure, thus regulating patterns of gene expression (104). Early life adversity, 
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such as being born SGA, has shown to alter DNA methylation in the brain and peripheral tissues, 
and often lead to adverse phenotypic changes (105). DNA methylation is potentially reversible 



































































FIGURE 1. Body weight (A) of AGA and SGA piglets increased over time (p<0.0001), but 
body weights of AGA and SGA piglets were significantly different throughout the entire study 
(p<0.0001). Wet brain weight (B) and brain:body weight ratio (C) of AGA and SGA piglets were 
significantly different (p<0.0001, p<0.01, and p<0.0001, respectively). No significant effect was 































FIGURE 2. The difference between the brain to body weight ratio of AGA and SGA piglets 
decreases over time, but is still significantly different at PD28 (p<0.001). All time-points are 










FIGURE 3. Performance of all piglets during acquisition and reversal phases of spatial T-maze 
task improved over time (p<0.0001), but SGA piglets reached criterion faster than AGA piglets 
























P – value2 






2ʹFL  Size Diet 
Size x 
Diet 
n 4 7 4 7     
Caudate 527.8 471.3 494.6 485.7 43.7 0.152 0.672 0.290 
Cerebellum 6488 5730 6355.4 5755.5 325.8 <0.001 0.746 0.633 
Cerebrum 51.7 49 47.3 46.6 7.0 0.622 0.347 0.775 
Corpus Callosum 378.2 360.7 381.9 325.9 70.7 0.312 0.666 0.592 
Fourth Ventricle 54.1 48.3 46.6 50.4 7.3 0.789 0.470 0.201 
Grey Matter 39420.4 33698.4 38454.4 33548.3 2783.9 0.001 0.693 0.773 
Hypothalamus 253.6 237.9 257.1 244.1 15.4 0.078 0.534 0.862 
Internal Capsule 1544.1 1486.8 1523.8 1479.1 96.3 0.303 0.774 0.897 
Lateral Ventricle 468.1 513.2 443.7 503.1 81.1 0.214 0.675 0.862 
Left Cortex 17839.8 15662 17022.7 15603.6 1061.9 0.003 0.420 0.484 
Left Hippocampus 510.9 447 492.4 453.8 35.3 0.010 0.743 0.483 
Medulla 1919.2 1742.4 1865 1765.9 114.6 0.027 0.792 0.506 
Midbrain 1942.9 1813.6 1886.9 1823.5 72.3 0.016 0.531 0.374 
Olfactory Bulb 2593.9 2280.9 2471.8 2222.6 213.4 0.017 0.409 0.768 
Pons 1134.4 1055.6 1074.4 1046 50.6 0.048 0.186 0.334 
Putamen 405.4 393.3 393.8 393.5 25.4 0.631 0.658 0.645 
Right Cortex 18374.7 16209.3 17520.9 16084.1 1019.5 0.002 0.350 0.484 
Right Hippocampus 515.7 459.2 505.1 463.2 32.5 0.007 0.841 0.657 
Thalamus 1722.1 1573.8 1677.1 1590.9 81.6 0.010 0.737 0.456 
Third Ventricle 49.1 46.6 46.5 43.8 6.2 0.408 0.387 0.983 
White Matter 16248.5 15360.8 16225.8 15445.4 1184.3 0.176 0.959 0.929 
Whole Brain 68656 59919.2 65967.5 60239.9 3240.5 <0.001 0.474 0.365 
1Values are means of 4-7 replicate pigs with MRI data collected at 27-29 d of age. Volumes are 
in units of mm3. 
2Size, main effect of birth weight (i.e. AGA vs. SGA); Diet, main effect of dietary intervention 
(i.e. 2ʹFL vs. CON); Size x Diet, interaction effect of birth weight and dietary intervention. 
Abbreviations: AGA, appropriate for gestation age; SGA, small for gestational age; CON, 
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2ʹFL Size Diet 
Size x 
Diet 
n 4 7 4 7     
Caudate 0.77 0.79 0.75 0.81 0.05 0.141 0.936 0.408 
Cerebellum 9.45 9.56 9.63 9.55 0.33 0.973 0.626 0.576 
Cerebrum 0.08 0.08 0.07 0.08 0.01 0.268 0.446 0.978 
Corpus Callosum 0.55 0.60 0.58 0.54 0.11 0.946 0.734 0.415 
Fourth Ventricle 0.08 0.08 0.07 0.08 0.01 0.279 0.649 0.392 
Grey Matter 57.42 56.24 58.29 55.69 2.80 0.177 0.832 0.648 
Hypothalamus 0.37 0.40 0.39 0.41 0.02 0.034 0.139 0.573 
Internal Capsule 2.25 2.48 2.31 2.46 0.11 0.002 0.711 0.405 
Lateral Ventricle 0.68 0.86 0.67 0.84 0.14 0.030 0.755 0.930 
Left Cortex 25.98 26.14 25.80 25.90 0.67 0.763 0.622 0.960 
Left Hippocampus 0.74 0.75 0.75 0.75 0.03 0.837 0.739 0.814 
Medulla 2.80 2.91 2.83 2.93 0.11 0.066 0.597 0.905 
Midbrain 2.83 3.03 2.86 3.03 0.09 0.001 0.782 0.735 
Olfactory Bulb 3.78 3.81 3.75 3.69 0.03 0.886 0.633 0.774 
Pons 1.65 1.76 1.63 1.74 0.05 <0.001 0.330 0.943 
Putamen 0.59 0.66 0.60 0.65 0.02 <0.001 0.851 0.687 
Right Cortex 26.76 27.05 26.56 26.70 0.54 0.473 0.366 0.811 
Right Hippocampus 0.75 0.77 0.77 0.77 0.03 0.534 0.491 0.745 
Thalamus 2.51 2.63 2.54 2.64 0.08 0.011 0.512 0.825 
Third Ventricle 0.07 0.08 0.07 0.07 0.01 0.413 0.515 0.753 
White Matter 23.67 25.64 24.60 25.64 1.39 0.045 0.494 0.487 
1Values are means of 4-7 replicate pigs with MRI data collected at 27-29 d of age. Relative 
volumes of regions of interest were obtained by determining the percent of whole brain volume 
for individual pigs prior to statistical analysis.  
2Size, main effect of birth weight (i.e. AGA vs. SGA); Diet, main effect of dietary intervention 
(i.e. 2ʹFL vs. CON); Size x Diet, interaction effect of birth weight and dietary intervention. 
Abbreviations: AGA, appropriate for gestation age; SGA, small for gestational age; CON, 





Table 3. Effects of SGA and 2ʹFL on grey matter percentage volumes as determined by 
voxel-based morphometric analysis 
    Number of 
Voxels1 
Peak-level Local maxima coordinates 





Cerebellum 1661 <0.001 11.9 -18.2 0.7 
Right Cortex 2849 <0.001 2.1 -12.6 14.7 
Thalamus 244 <0.001 3.5 8.4 2.1 
Cerebellum 123 <0.001 9.8 -14.0 -11.2 
Left Cortex 96 <0.001 -5.6 11.2 14.7 
Left Cortex 228 <0.001 -5.6 27.3 1.4 
Right Cortex 308 <0.001 4.2 4.2 16.1 
Cerebellum 33 <0.001 -10.5 -14.7 -11.2 
Right Cortex 57 <0.001 0.0 23.8 -2.1 
Left Hippocampus 42 <0.001 11.9 19.6 10.5 
Right Cortex 77 <0.001 7.7 21.7 -6.3 
Left Cortex 238 <0.001 -14.0 4.9 12.6 





Right Cortex 32 <0.001 14.7 11.2 4.2 
Size x Diet  No significant findings         
1Clusters > 20 were included in analysis with threshold set at p<0.001 
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2ʹFL Size Diet 
Size x 
Diet 
Fractional Anisotropy, FA Units 
        Corpus Callosum 0.269 0.263 0.282 0.266 0.014 0.141 0.279 0.451 
Caudate 0.330 0.291 0.307 0.295 0.016 0.006 0.255 0.112 
Internal Capsule 0.417 0.403 0.410 0.397 0.012 0.037 0.327 0.944 
Thalamus 0.300 0.320 0.316 0.326 0.018 0.117 0.239 0.552 
Left Hippocampus 0.293 0.299 0.296 0.302 0.017 0.524 0.743 0.989 
Right Hippocampus  0.278 0.287 0.289 0.291 0.015 0.496 0.338 0.658 
Cerebellum 0.165 0.167 0.166 0.169 0.011 0.713 0.768 0.867 
Left White Matter 0.315 0.308 0.310 0.310 0.004 0.091 0.414 0.078 
Right White Matter 0.312 0.307 0.316 0.306 0.004 0.002 0.616 0.188 
Total White Matter 0.313 0.307 0.312 0.307 0.003 0.002 0.769 0.736 
Whole Brain 0.316 0.309 0.314 0.310 0.003 0.002 0.692 0.248 
         Radial Diffusivity, x 10^-3 mm^2 / sec 
        Corpus Callosum 1.124 1.172 1.076 1.046 1.455E-04 0.901 0.254 0.609 
Caudate 0.785 0.906 0.809 0.923 8.153E-05 0.011 0.633 0.926 
Internal Capsule 0.650 0.660 0.653 0.655 2.041E-05 0.562 0.883 0.701 
Thalamus 0.743 0.750 0.754 0.758 2.000E-05 0.589 0.371 0.872 
Left Hippocampus 0.997 1.037 1.033 1.018 1.131E-04 0.825 0.882 0.640 
Right Hippocampus  0.993 0.978 1.029 0.982 7.401E-05 0.419 0.595 0.677 
Cerebellum 1.064 1.003 1.009 1.039 5.429E-05 0.587 0.721 0.119 
Left White Matter 0.819 0.831 0.835 0.824 1.970E-05 0.924 0.691 0.267 
Right White Matter 0.804 0.817 0.820 0.825 1.961E-05 0.375 0.250 0.700 
Total White Matter 0.811 0.825 0.827 0.823 1.872E-05 0.581 0.472 0.383 
Whole Brain 0.822 0.836 0.837 0.837 2.069E-05 0.530 0.456 0.530 
         Axial Diffusivity, x 10^-3 mm^2 / sec  
        Corpus Callosum 1.695 1.744 1.661 1.575 2.070E-04 0.868 0.346 0.528 
Caudate 1.311 1.413 1.296 1.453 1.030E-04 0.024 0.807 0.610 
Internal Capsule 1.277 1.266 1.273 1.242 2.122E-05 0.065 0.211 0.343 
Thalamus 1.170 1.236 1.229 1.262 5.298E-05 0.080 0.135 0.547 
Left Hippocampus 1.573 1.642 1.632 1.612 1.495E-04 0.752 0.852 0.570 
Right Hippocampus  1.528 1.528 1.629 1.551 9.491E-05 0.432 0.213 0.434 
Cerebellum 1.352 1.283 1.297 1.326 6.330E-05 0.538 0.850 0.145 
Left White Matter 1.329 1.335 1.346 1.324 2.353E-05 0.513 0.785 0.258 
Right White Matter 1.303 1.313 1.334 1.323 2.785E-05 0.968 0.170 0.461 
Total White Matter 1.315 1.326 1.339 1.321 2.391E-05 0.778 0.453 0.258 
Whole Brain 1.339 1.348 1.357 1.350 2.772E-05 0.964 0.469 0.582 
         Mean Diffusivity, x 10^-3 mm^2 / sec 
        Corpus Callosum 1.314 1.363 1.270 1.223 1.655E-04 0.995 0.288 0.574 
Caudate 0.961 1.075 0.972 1.099 8.806E-05 0.015 0.699 0.884 
Internal Capsule 0.859 0.862 0.860 0.850 1.928E-05 0.762 0.571 0.538 
Thalamus 0.885 0.912 0.912 0.926 2.844E-05 0.178 0.178 0.660 
Left Hippocampus 1.189 1.239 1.232 1.216 1.245E-04 0.793 0.870 0.611 
Right Hippocampus  1.172 1.161 1.229 1.172 8.001E-05 0.416 0.410 0.576 
Cerebellum 1.160 1.096 1.105 1.134 5.714E-05 0.566 0.770 0.128 
Left White Matter 0.989 9.990 1.005 0.991 2.083E-05 0.863 0.720 0.248 
Right White Matter 0.970 0.982 0.991 0.991 2.213E-05 0.618 0.208 0.598 
Total White Matter 0.979 0.992 0.997 0.989 2.024E-05 0.814 0.463 0.319 
Whole Brain 0.995 1.007 1.011 1.008 2.294E-05 0.684 0.470 0.547 
1Values are means of  4-7 replicate pigs with MRI data collected at 27-29 d of age. 
2Size, main effect of birth weight (i.e. AGA vs. SGA); Diet, main effect of dietary intervention (i.e. 2ʹFL vs. CON); Size x 
Diet, interaction effect of birth weight and dietary intervention 
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Table 5. Effects of birth weight and 2ʹFL on hippocampal metabolism as determined 














2ʹFL Size Diet 
Size x 
Diet 
n 9 9 8 9 
    NAA + NAAG 5.014 5.739 5.472 5.581 3.778 0.279 0.695 0.423 
GPC + PCh 1.287 1.443 1.301 1.494 1.011 0.146 0.784 0.877 
Cr + PCr 4.222 4.770 4.602 4.575 3.097 0.271 0.693 0.225 
n 8 8 6 9 
    Glu + Gln 7.933 8.424 8.725 8.558 6.222 0.770 0.407 0.555 
1Values are means of 6-9 replicate pigs with MRI data collected at 27-29 d of age 
2Size, main effect of birth weight (i.e. AGA vs. SGA); Diet, main effect of dietary 
intervention (i.e. 2ʹFL vs. CON); Size x Diet, interaction effect of birth weight and dietary 
intervention. 
Abbreviations: AGA, appropriate for gestational age; SGA, small for gestational age; 2ʹFL, 
2ʹ-fucosyllactose; NAA + NAAG, N-acetylaspartate + N-acetylaspartylglutamate; GPC + 
PCh, glycerophosphocholine + phosphocholine; Cr + PCr, creatine + phosphocreatine; Glu + 














Figure 4. Brain volume measured by MRI did not reveal a significant effect of dietary treatment 
for the whole brain, but a main effect of size was observed such that SGA brain volume was 
























































Figure 5. Visualization of relative expression of the 529 DEGs in each piglet 
(blue=down-regulation; red=up-regulation). Each row represents a gene and its 
relative expression. Piglets were clustered on overall expression patterns.  
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